Peptide glossary.

The molecular building blocks that link together to form peptides and proteins, each consisting of an amine group, a carboxyl group, and a unique side chain.

Relating to the metabolic process of building and synthesizing complex molecules — particularly promoting muscle tissue growth, protein synthesis, and recovery.

The biological process by which new blood vessels form from pre-existing vessels, supplying oxygen and nutrients to healing or growing tissue.

The cellular self-cleaning process by which cells break down and recycle damaged proteins, organelles, and other cellular debris.

Common abbreviation for bacteriostatic water, the standard solvent used to reconstitute lyophilized peptides for injection.

Sterile water containing 0.9% benzyl alcohol as a preservative, used to reconstitute peptides for multi-dose injectable use.

The fraction of an administered dose that reaches systemic circulation in active form, expressed as a percentage.

A highly selective semipermeable membrane formed by specialized endothelial cells that separates circulating blood from the brain and central nervous system.

A unique numerical identifier assigned by the Chemical Abstracts Service to every chemical substance, providing an unambiguous way to identify compounds across languages and naming systems.

A structured research study conducted in human participants to evaluate the safety, dosing, efficacy, or side effect profile of a medical intervention.

Certificate of Analysis — a document from a third-party laboratory confirming the identity, purity, and potency of a research compound.

A defined period of peptide or compound administration, typically followed by an equal or longer period off to prevent desensitization or maintain receptor sensitivity.

Small signaling proteins secreted by immune and other cells that regulate inflammation, immune response, and intercellular communication.

The progressive reduction in a cell's or receptor's response to a compound following repeated or prolonged exposure, resulting in diminished effect over time.

Originating or produced naturally within the body, as opposed to being introduced from an external source.

Originating from outside the body and introduced through administration, as opposed to being naturally produced internally.

The regulatory classification assigned by the U.S. Food and Drug Administration indicating whether a compound is approved, investigational, or unregulated for human use.

An endogenous peptide hormone primarily produced in the stomach that stimulates appetite, promotes fat storage, and triggers growth hormone release from the pituitary.

Growth Hormone Releasing Hormone — a peptide produced by the hypothalamus that signals the pituitary gland to secrete growth hormone.

Growth Hormone Releasing Peptide — a class of synthetic peptides that stimulate the pituitary to release growth hormone by acting on ghrelin receptors.

Glucagon-like peptide-1, an incretin hormone released by intestinal cells after eating that stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite.

A pituitary-secreted peptide hormone that stimulates cell growth, reproduction, and regeneration, and drives IGF-1 production in the liver.

The time it takes for the concentration of a compound in the body to decrease by half, determining how frequently it needs to be dosed.

The tendency of biological systems to maintain stable internal conditions — such as temperature, pH, hormone levels, and blood pressure — through dynamic regulatory feedback mechanisms.

Insulin-Like Growth Factor 1 — a hormone produced primarily by the liver in response to growth hormone, mediating most of GH's anabolic and tissue-repair effects.

An injection delivered directly into muscle tissue, abbreviated as IM, providing faster absorption than subcutaneous injection.

International Unit — a measurement of a biological substance defined by its biological activity rather than its mass, used for hormones like HGH and insulin.

An initial higher dose administered at the start of a protocol to rapidly achieve therapeutic concentration, before transitioning to a lower maintenance dose.

A freeze-drying process that removes water from a peptide solution under low pressure, leaving a stable powder that can be stored at room temperature.

Microgram — a unit of mass equal to one millionth of a gram (0.000001 g), the standard unit for dosing most research peptides.

Membrane-bound organelles found in most eukaryotic cells that generate the majority of cellular energy in the form of ATP through oxidative phosphorylation.

The brain's ability to reorganize itself by forming new neural connections, strengthening existing pathways, and pruning unused ones in response to experience, learning, or injury.

The preservation of neuronal structure and function against damage, degeneration, or death caused by injury, disease, oxidative stress, or excitotoxicity.

The use of an FDA-approved drug for a purpose, population, dose, or route of administration not included in its official approved labeling.

Post-Cycle Therapy — a protocol used after a cycle of compounds that suppress endogenous hormone production, aimed at restoring natural hormonal function.

A short chain of amino acids linked by peptide bonds, typically 2–50 amino acids in length.

The covalent chemical bond formed between the carboxyl group of one amino acid and the amine group of another, releasing a water molecule in the process.

The study of how the body absorbs, distributes, metabolizes, and excretes a drug or compound over time — often summarized as ADME.

Research conducted in cell cultures or animal models before a compound advances to human clinical trials, used to assess basic safety, efficacy, and mechanism of action.

A protein molecule, typically embedded in a cell membrane or located inside a cell, that binds to a specific signaling molecule (ligand) and triggers a corresponding biological response.

The process of mixing a lyophilized (freeze-dried) peptide powder with bacteriostatic water to create an injectable solution.

The sterile liquid — typically bacteriostatic water or sterile water for injection — used to dissolve a lyophilized (freeze-dried) peptide powder into solution for administration.

Selective Androgen Receptor Modulator — a class of compounds that bind androgen receptors in a tissue-selective manner, distinct from and not classified as peptides.

A substance that stimulates another cell or gland to secrete a hormone or other compound, acting upstream to trigger endogenous release rather than supplying the hormone directly.

The time required for the concentration of a compound in the blood to decrease by 50% from its peak level, reflecting the rate at which it is eliminated from systemic circulation.

An injection administered into the fatty tissue just beneath the skin, abbreviated as SubQ or SC.

An injection technique that delivers a compound into the fatty tissue layer just beneath the skin, above the muscle, typically using a short fine-gauge needle.

Repetitive DNA sequences (TTAGGG in humans) that cap the ends of chromosomes, protecting them from degradation and fusion, and shortening with each cell division.

An adaptive increase in the number, density, or sensitivity of receptors or cellular components in response to reduced stimulation or signal deprivation.

The degree and quality of blood vessel development and distribution within a tissue, reflecting the density and function of the local vascular network.